What is the target price for AbbVie (abbv) shares?

16 equities research analysts have issued 1-year target prices for AbbVie's shares. Their ABBV share price forecasts range from $140.00 to $200.00. On average, they expect the company's share price to reach $161.12 in the next twelve months. This suggests a possible upside of 1.7% from the stock's current price.

What does AbbVie stand for?

About the company. AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating condit.

What did Pfizer and AbbVie announce?

Pfizer and AbbVie (ABBV) announce new research collaborations. AbbVie (ABBV) closed at $165.99 in the latest trading session, marking a +0.36% move from the prior day. The Icelandic biotech company has a deal to expand the reach of its Humira biosimilar in Eastern Europe.

Should you buy AbbVie (abbv) or Coca-Cola (KO)?

A couple of potential stocks that you can confidently hold forever are AbbVie (NYSE: ABBV) and Coca-Cola (NYSE: KO). What makes AbbVie a solid buy-and-hold investment is that the company is diverse, has excellent margins, and generates plenty of free cash flow.